Aprogen Biologics Inc. (KRX: 003060)

Aprogen Biologics Revenue

Aprogen Biologics had revenue of 15.19B KRW in the quarter ending June 30, 2024, a decrease of -43.89%. This brings the company's revenue in the last twelve months to 73.64B, down -5.14% year-over-year. In the year 2023, Aprogen Biologics had annual revenue of 87.36B with 34.01% growth.

• Revenue (ttm): 73.64B
• Revenue Growth: -5.14%
• P/S Ratio: 0.64
• Revenue / Employee: 195.32M
• Employees: 377
• Market Cap: 140.67B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	87.36B	22.17B	34.01%
Dec 31, 2022	65.19B	8.71B	15.42%
Dec 31, 2021	56.48B	3.16B	5.93%
Dec 31, 2020	53.32B	2.42B	4.75%
Dec 31, 2019	50.90B	5.51B	12.13%